Biologics for Severe Asthma Present Opportunities for Pharma

Drug therapy workups may reveal candidates for immune therapy and provide chance for interventions.

Related Keywords

United States , United Kingdom , British , Benralizumab Fasenra , Omalizumab Xolair , Regeneron Sanofi , Mepolizumab Nucala , Reslizumab Cinqair , Dupilumab Dupixent , Teva Respiratory , Global Asthma Initiative , Global Initiative For Asthma , Genentech , Most Recent National Asthma Data , Prevention Program , Glaxosmithkline , Expert Panel , Genentech Inc , Astrazeneca , National Asthma Education , Amgen , Centers For Disease , Prevention Guidelines , Global Initiative , Asthma Education , Expert Panel Report , Asthma Summary Report , Allergy Clin , Recent National Asthma , Disease Control , Accessed April , Asthma Management , Global Asthma , Can Respir , Ann Allergy Asthma ,